Puma Biotechnology
PBYI
PBYI
122 hedge funds and large institutions have $362M invested in Puma Biotechnology in 2020 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 41 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 127 → 122 (-5)
20% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 20
Holders
122
Holding in Top 10
–
Calls
$4.3M
Puts
$3.17M
Top Buyers
| 1 | +$11.6M | |
| 2 | +$5.32M | |
| 3 | +$3.69M | |
| 4 |
JGC
J. Goldman & Co
New York
|
+$2.45M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$2.03M |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$5.94M | |
| 3 | -$3.53M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.29M |
| 5 |
Goldman Sachs
New York
|
-$2.15M |